Skip to main content

S. 3353

Referred to Committee

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

Introduced 2/27/2020•116th Congress•Senate

Latest Action

Read twice and referred to the Committee on Finance.

2/27/2020 • Senate

Summary

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.

Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.

Introduced in Senate • 2/27/2020

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Congressional oversightDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care coverage and accessHealth promotion and preventive careMedicareOrgan and tissue donation and transplantationPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (26)

Party Breakdown

10
Democrats
16
Republicans
0
Independents

Sponsor

S[
Sen. Cassidy, Bill [R-LA]

Republican • LA

Sponsored 2/27/2020

Cosponsors (25)

S[
Sen. Durbin, Richard J. [D-IL]

D-IL

Joined 2/27/2020

S[
Sen. Ernst, Joni [R-IA]

R-IA

Joined 2/27/2020

S[
Sen. Shaheen, Jeanne [D-NH]

D-NH

Joined 2/27/2020

S[
S[
Sen. Young, Todd [R-IN]

R-IN

Joined 2/27/2020

S[
Sen. Brown, Sherrod [D-OH]

D-OH

Joined 3/11/2020

Bill Journey

Originated in the Senate

Introduced

February 27, 2020

Read twice and referred to the Committee on Finance.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate2/27/2020

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors25